A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Addiction
This study is completed in the United States. It focuses on Addiction.
In United States
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on Addiction.
In United StatesThis study exists to explore whether the medication MM120 could improve care and understanding. Researchers are trying to understand whether the medication MM120 can give earlier or clearer feedback during care.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is comparing Transcranial Direct Current Stimulation with Healthy Control for people with Attention Deficit Hyperactivity Disorder. Participants receive Transcranial Direct Current Stimulation or Healthy Control and complete study visits and assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United StatesThis study was terminated in the United States. It focuses on ADHD.
In United StatesThis study is completed in the United States. It is testing Double-Blind Placebo Controlled Trial of Riluzole for depression in bipolarity.
In United StatesThis study is completed in the United States. It is testing quetiapine for depression.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.